文献速递疝与腹壁外科围术期管理与 ERAS

免疫抑制状态与术前糖皮质激素治疗对腹股沟疝修补术风险的影响

Are immunosuppressive conditions and preoperative corticosteroid treatment risk factors in inguinal hernia repair?
PubMed 文献 · Surg Endosc · 2020-06-18

基于Herniamed注册数据,2312/142488例(1.6%)原发性单侧腹股沟疝修补患者有免疫抑制状态和/或术前糖皮质激素治疗史,倾向性评分匹配后形成2297对。匹配分析未发现这类患者在手术部位感染、血清肿、术后并发症、复发及疼痛等结局上存在劣势。

要点

  • 免疫抑制和/或术前激素治疗不增加腹股沟疝修补术后伤口并发症风险。
  • 匹配后手术部位感染率0.65% vs 0.70%、血清肿1.22% vs 1.57%,均无统计学差异。
  • 术后总并发症率3.40% vs 4.31%(p=ns),未见负性影响。

核心结论

  • 原发性单侧腹股沟疝手术中,免疫抑制状态和/或术前糖皮质激素治疗似乎对伤口并发症无负性影响。

研究设计与样本

  • 基于Herniamed注册数据的分析,142488例原发性单侧腹股沟疝修补患者中2312例(1.6%)有免疫抑制状态和/或术前糖皮质激素治疗史。
  • 采用倾向性评分匹配形成2297对(99.4%)特征可比的患者,匹配对中82.76%为男性。
  • 手术方式包括腔镜/内镜技术1010例(44.0%)、开放技术1225例(53.3%)、其他技术62例(2.7%)。

主要发现

  • 匹配 Pair 分析未发现免疫抑制和/或术前激素治疗患者在主要结局指标上存在劣势。
  • 手术部位感染率0.65% vs 0.70%(无统计学差异),血清肿率1.22% vs 1.57%(无统计学差异)。
  • 术后总并发症率3.40% vs 4.31%(p=ns),另有5对匹配出现0.22%的一致性事件。

临床怎么用

  • 对于有免疫抑制状态和/或术前糖皮质激素治疗史的原发性单侧腹股沟疝患者,可不将其视为伤口并发症的高危因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Immunosuppressive conditions and/or preoperative corticosteroid treatment have a negative influence on wound healing and can, therefore, lead to higher rates of surgical site infections (SSIs) and seromas. For inguinal hernia, no such studies have been carried out to date. METHODS: In an analysis of data from the Herniamed Registry, 2312 of 142,488 (1.6%) patients with primary unilateral inguinal hernia repair had an anamnestic history of an immunosuppressive condition and/or preoperative corticosteroid treatment. Using propensity score matching, 2297 (99.4%) pairs with comparative patient characteristics were formed. These were then compared using the following primary outcome criteria: intra- and postoperative complications, complication-related reoperations, recurrence at one-year follow-up, pain on exertion, pain at rest, and chronic pain requiring treatment at one-year follow-up. Of the 2297 matched pairs with primary unilateral inguinal hernia repair, 82.76% were male patients. 1010 (44.0%) were operated in laparo-endoscopic techniques (TEP, TAPP), 1225 (53.3%) in open techniques (Bassini, Shouldice, Lichtenstein, Plug, TIP, Gilbert, Desarda), and 62 (2.7%) in other techniques. RESULTS: The matched pair analysis results did not identify any disadvantage in terms of the outcome criteria for patients with an anamnestic history of immunosuppressive condition and/or preoperative corticosteroid treatment (yes vs no). In particular, no disadvantage was noted in the rate of surgical site infections (0.65% vs 0.70%; ns) or seromas (1.22% vs 1.57%; ns). The overall rates of postoperative complications were 3.40% vs 4.31% (p = ns) (plus 0.22% concordant events in five matched pairs). CONCLUSION: In primary unilateral inguinal hernia surgery, an immunosuppressive condition and/or preoperative corticosteroid treatment does not appear to have a negative influence on wound complications.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Varga M, Köckerling F, Mayer F, et al. Are immunosuppressive conditions and preoperative corticosteroid treatment risk factors in inguinal hernia repair? Surg Endosc. 2020. PMID: 32556698. doi:10.1007/s00464-020-07736-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。